*****This thread is setup mainly to gain information
relating to Mediwatch in a quick and easy way and IS IN NO WAY A
RECOMMENDATION TO BUY!********


Mediwatch-A Synopsis:
Mediwatch was established in 1996 and has developed a range of specialist
medical equipment for the diagnosis of urological disorders.The group joined the
AIM in 2000 through a reverse into Prostcare plc,which at the time was valued at
8m.While the vast majority of sales were generated in the UK,there was a
substantial indirect export business involving a number of agents,supplying into
Europe,North America,Australasia and Asia,notably Japan.
Group revenues are set to increase rapidly following the acquisition of the former
Medtronic Urodynamis Division,which has introduced a fundamental presence in
North America.The deal was in 2006 with the sales division building from 2007.
With the inclusion of the Medtronic systems now owned by Mediwatch they now
can offer a 'One Stop Shop' for the diagnosis of various urology disorders with the
benefit of Mediwatch systems having the ability to electronically send data from the
various tests to a central data base!Oh and plus the added bonus of PSAwatch and
now PCA3plus!

More than 30 million PSA tests are performed annually in the USA alone!

CHARTS

FUTURE EVENTS AND LATEST
NEWS

Just for the record and to even things up,this is Treblewide's view (near end
of 2008):

"in short 3p by chrimbo and a real chance if they do not get rid of management they
will go into receivership.....when they bough the MDT business I said at the time it
must have been a bag of shite as they only paid buttons for it.......looks like that was
fairly correct......i feel sorry for shareholders"

Treblewide has been filtered from my eyes for his abuse,lies and general behavior but
it's a free country (I think) so do as you see fit.


It started with:

Treblewide - 05 Jun 2007 15:49 - 33 of 1747
still short

Treblewide - 18 Jun 2007 00:24 - 69 of 1747
interesting stuff from that article...very few men die from prosate cancer and it is not an agressive disease....treatment can be worse than the disease.......kind of suggests their whole business model is based on sand to me.......but hey who wants a balanced view.

Treblewide - 18 Jun 2007 00:31 - 76 of 1754
exercise and sex may cause a raised PSA...so you guys may have stumbled on a test for fit shaggers :-)

I am gonna name Me-Di-Watch

Gonna-go-bust-soon-iwatch

Treblewide - 18 Jun 2007 10:59 - 85 of 1754
minder...i do not make light of prosate cancer....show me one post where I do...i make fun out of this company yes but not the disease so wind yer neck in pal.

show me any trace of a profit and i will maybe change my mind

Treblewide - 18 Jun 2007 15:54 - 97 of 1754
minder made a small loss yes which I have more than made up for shorting it........and i guess your average holding is 3p.....aye right.

Aalso I closed out my short at 8p for a loss of the spread if memory serves me correctly.

currently short from 13.25....i thank you and goodnight

Treblewide - 23 Jul 2007 12:36 - 154 of 1747
more of the same......thank god i still do not own shares in this lot...will they ever
make a penny profit....looks doubtful......cannot even manage a small supply chain.


ect ect ect

with the last few posts:

Treblewide - 30 Mar 2009 09:16 - 1704 of 1754
you are a lunatic mick.....words fail me.

and ps i only post under treblewide on any financial web site....i know you cannot say the same......you have been calling this as a buy and nothing but a buy for about 7 years...it says it all really about your stock picking ability

i notice the downtrend ins now establishing itself....re-visit of the lows again by the looks of things

Treblewide - 30 Mar 2009 22:41 - 1712 of 1754
mick no i dont know what each product does...i dont think that is important...the numbers tell everything and even though you must spend hours on web sites searching for stuff that is not even related to MDW you fail to grasp the basics...they consistently lost money and now seem to be making some...my call to 3p was correct and i think if they had not got their shit together they could have gone under

i was not interested in them as a long play while they were loosing money depsite whatever rubbish you posted regarding piss sticks or whatever you bang on about.

and yes it was poor trading..having an avergae of 12 and averaging down to 6-7p while they were at 3p....is terrible trading...that cannot even be debated...the very fact you know so much about the products means you have fallen in love with this company......which is very dangerous when investing....

the numbers are the important things...i was right on 3p, the company is posting slightly better figures but we are in a bear market which has not bottomed yet so the price will fall further

you are a 1 trick pony that posts irrelevant links...dont bother to respond i can be bothered getting into a debate with you.....away and cut and paste some more flags

toodlepip

**************************************************************

I have been chased from here and now ADVFN,has the boy got a problem?

treblewide - 3 Aug'09 - 14:46 - 22345 of 22412


post 22342 is classic.....so mick advfn is not a good source when the consensus is sell?

begs the question why you spend so much time polluting it with your bull tripe?

question....so MDW share price has gone up, it has gone down etc etc...during all of that time has mick ever been able to find any subjectivity in his posting ie has he ever critisised anything?

i really think he may be getting paid by MDW...the whole thing is very bizzare.

mick i notice you referred to your threads as "promotion of Mediwatch"

can you confirm if you are getting financially rewarded by the company for this?

treblewide - 3 Aug'09 - 23:55 - 22371 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....



treblewide - 4 Aug'09 - 00:19 - 22373 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....

treblewide - 4 Aug'09 - 10:49 - 22379 of 22412


still time to get out at 6p.....dont understand why you would not sell at 6p when they are obviously going to half in value...if you are a long term mdw bull you can buy twice as many shares at 3p and maybe possibly one day see a profit on your holding?



treblewide - 4 Aug'09 - 12:44 - 22381 of 22412


last chance to sell at 6p for your shares folks


treblewide - 4 Aug'09 - 14:48 - 22387 of 22412


so question...is psawatch is so great...why has there been no huge surge in revenue figures from UK and Europe on the back of it being sold?

the whole reason a lot of you hold this is psawatch...it has not made them any money in Europe which could be argued when taken as a whole is not much smaller than the USA.....this company is not going to change overnight with US approval...at bets it would be a selling opportunity for long term holders

i really think a lot of you have to ignore some of the nonsense ramping going on here...the company is draining cash and there margins are reducing (despite this wonder PSA machine they have for sale)

i really think the future looks bleak for mediwatch...if someone can put in concise terminology why MDW is a buy i am all ears....dont point me at fairfax report...they are a bunch of clowns as well...that interim report is shocking and i mean really poor.

costs out of control...margins squeezed, cash running out...no real revenue growth, does this sound like a growth company to you?

sell at 6p


treblewide - 4 Aug'09 - 15:50 - 22391 of 22412


god i have heard it all now...mick can you counter my points about declining margins and cash issues without nonsense posts about peopel having insider information...what a crock and what a clown.

so just so i have this straight in my head...when you put in effort to ramp these shares it is all great and you expect cuddles? (and if anyone disagrees you throw your toys out the pram liek an old woman)

when i put up a few posts to explain why i am short it is an organised attempt to get the share price down because i have insider inforamtion from the US?

were you the Iraqi information minister in a previous role? lol


treblewide - 5 Aug'09 - 19:24 - 22409 of 22412


lol.....shares getting sold today at 5.75.....next stop 3p...

treblewide - 4 Aug'09 - 12:44 - 22381 of 22408 edit


last chance to sell at 6p for your shares folks




treblewide - 5 Aug'09 - 19:29 - 22410 of 22412


i wonder what thier overdraft is limited to....1M?

if so they have 12 months of life left at current perfomance...how many of you hlders have considered the chances of them going bust?....i would not rule it out...would love to know how much further the banks will let them go into debt before they pull the plug

treblewide - 5 Aug'09 - 19:37 - 22411 of 22412


seriously if i were a holder i would look at the interims and ask how much longer can they go on burning cash.......and with all the averaging down the bulls have done over the years i bet some are more exposed than they should be....good luck...think you might need it




ANYWAY

http://mediwatch.blogspot.com/

The Society for Urodynamics and Female Urology (SUFU) Winter meeting finished today with the next event that MDW will be attending being the Society of Urologic Nurses and Associates (SUNA) Annual Symposium:



SUNA-Annual Symposium: Incontinence and Pelvic Floor Disorders.

Incontinence and Pelvic Floor Disorders Focus of Society of Urologic Nurses and Associates Annual Symposium

"Urologic nurses and health care professionals will explore basic and advanced practice at the Society of Urologic Nurses and Associates (SUNA) Annual Symposium: Incontinence and Pelvic Floor Disorders, March 11-14, 2009, at the Hyatt Regency, San Francisco, CA. The symposium will highlight the most current advances and treatments for incontinence and pelvic floor disorders as well as urodynamics.

Attendees will hear from a dynamic faculty of nurse practitioners, physicians and physical therapists in preconference workshops and education sessions on such topics as incontinence, pelvic pain, pharmacology for pelvic disorders, and advanced practice clinical issues in men and women, young and old. Participants will also have the opportunity to earn continuing nursing education (CNE) credits, attend research luncheons, network with colleagues and explore the exhibit hall to learn about technologies and products."

The link for the above.....

Mediwatch are of course a corporate member of SUNA:

Corporate Members

Mediwatch PLC
1501 Northpoint Parkway Suite 103
West Palm Beach, FL 33407
Telephone: 888-471-2611
Web site: www.Mediwatch.com

Mediwatch are manufacturers and suppliers of high-technology urology products for the screening, diagnosis and assessment of a variety of clinical disorders. We focus on innovation in point-of-care devices, enabling clinicians to make rapid and efficient decisions.

Our range of diagnostic devices for urology includes:

Sensic Clinic
Complete urodynamics system, with Pressure-flow and UPP studies built in, and optional video cystometry. Also available with the well-established Duet Logic software.

Sensic Portable
Portable, small footprint system designed for clinicians with multiple sites to cover, or a restricted working area.

Duet Encompass urodynamics systems
Advanced urodynamics systems offering Anorectal manometry, Neuro-urodynamics, simple Biofeedback and cavernosometry

Portascan+ & Multiscan PVR
Portable and user-friendly real-time visual automatic bladder scanner
Designed for post-void residuals and use in concert with a urodynamics system

Urodyn 1000 and Portaflow uroflow devices
Spinning disc or weight-cell flowrate measurement

New Portaflow Advanced
Uroflow measurement system with Bluetooth connection to a Windows laptop

Urodynamic Consumables
A complete range including water & air charged catheters, EMG electrodes and pump tubing sets

EMR Connectivity
Three levels of communication with EMR systems via HL7 are available.

Mediwatch PLC-SUNA:Corporate Member

A bit off topic but I thought I'd share a bit of Bauhaus before bed:

Bauhaus ~ Rosegarden Funeral of Sores

I see the debate on Polyclinics v GP's is still rolling on:

"NHS 'does not need polyclinics'

Average-sized GP surgeries are just as good as "super-surgeries" at providing extra services, a study suggests.

Ministers in England have asked health chiefs to create a network of polyclinics to provide extra care, such as diabetes clinics and minor surgery.

But a Kent-based GP's study of 384 practices found no difference between the range of extra services offered by standard surgeries and polyclinics.

The government said polyclinics would provide a valuable service to patients.

Every NHS trust in the country has been told to set up at least one polyclinic, with a whole network being created in London."


"The Department of Health said it was investing 250 million in new services to improve access to GP services.

"This includes 152 GP health centres, open 8am-8pm, seven days a week, which can be used by any member of the public on top of, not instead of, their existing GP surgery," a spokeswoman said."

http://news.bbc.co.uk/1/hi/health/7915727.stm

Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3)

http://www.urotoday.com/images/british/bju3_2009_02.pdf

An upper age limit for first-line treatment of localized disease?
Posted on March 2, 2009 by E. Michael D. ("Mike") Scott

For many years there has been intense discussion regarding who needs early detection and early (first-line) treatment for localized prostate cancer.

We know that many men have indolent disease (but we dont know who or how many). We know that most men who are diagnosed with early stage, localized disease of low or intermediate risk will take several years to progress to metastatic disease and to show any significant signs or symptoms of that disease. And we know that many men who receive early treatment for localized prostate cancer have significant adverse effects (harms) that impact their quality of life.

So this raises two questions:

When do the potential harms of first-line treatment for localized disease start to seriously outweigh the potential benefits?
Does it, at some point, become unethical to give first-line treatment to an elderly man for localized disease, however much he may desire it?

Why is this question coming up now? you ask. Because of a case report that appears in a recent publication.

http://prostatecancerinfolink.net/2009/03/02/an-upper-age-limit-for-first-line-treatment-of-localized-disease/#more-4393

Just lobbing these links here for now,relating to HL7:

http://www.hl7.org/

http://www.hl7.org.uk/

Health Level 7 Project Responsible for the research and development of the HL7 protocol to be use in Mediwatch

Not sure if Mark Emberton will be speaking at the Stockholm EAU congress as a non-executive Director of MDW or as an expert in the field of prostate cancer,probably the latter but all good publicity!

Prostate Cancer

Per-Anders Abrahamsson, Malm(SW), Frans M.J. Debruyne, Arnhem (NL), Mark Emberton, London (GB) and Manfred Wirth, Dresden (DE).

EAU TV is part of the EAU's initiatives to actively use contemporary electronic media such as podcast, webinars and TV news. For example, all congress sessions will be webcasted.

http://www.medicalnewstoday.com/articles/140822.php

i see you are still ramping away...i would be selling into any strenght...bear market an all that....i would think it will re-test the lows.

anyway best of luck and happy ramping

I see the Prostate Cancer Charity still refuse to mention the PSA test by name but a very good video all the same.

The charity give the impression that all they are interested in is finding the perfect test and cure for PC and disregard what is available today! Their public awareness campaigns are excellent though which encourage PSA testing and therefore highlights PSAwatch.


http://www.pantsalot.org.uk/why-we-need-your-help.php

http://www.prostate-cancer.org.uk/help/corporate/case_studies/study_17.asp

It would take a braver man than me to say that these positions in MediGroup Asia Ltd were related to MDW's product line.As there appears to be no website for the company I think it's worth posting as it does mention MDT.Vietnam is the 13th largest country by population in the world with over 80 million.

"MediGroup Asia Ltd., was established in 1995, a leader provider of clinical diagnostic and high tech medical devices in the Indochina region. Our products are including the famous brands: Medtronic Inc, Behnk GmbH, Human GmbH and Konelab systems of ThermoFisher Inc. collaboration with GE Life Sciences and GE Compact Ultrasound."

03/03/2009 Sales Executive/ Repersentative
03/03/2009 Service Engineer (HCM & HN)
27/02/2009 PRODUCT SPECIALIST

http://vinacareers.com/view.php?company_id=11481958&type=search&auth_sess=m5tsm73kl9t2g3c1loinml8ge5&ref=f3032de4e7f8f0aace570c44a&language=english

Think I'll do a bit of research on Vietnam and it's Healthcare,just out of interest.

Paying for Health Care in Vietnam:Extending Voluntary Health Insurance Coverage (1999)
Urology In The Vietnam War: Casualty Management and Lessons Learned
Friendship Bridge Urology Project (late 90's?)
Week 2 in Ho Chi Minh City
Federation of Asean Urological Associations
Vietnam vets face dangers decades later-Sept. 15, 2008
Veterans Exposed To Agent Orange Have Higher Rates Of Prostate Cancer Recurrence (21 May 2007 )
Health, Nutrition & Population in Vietnam
WHO's current programmes in Viet Nam
Vietnam military service history and prostate cancer (December 16, 2005)
Vietnam Veterans Association of Australia



CONCLUSION

Prior studies investigating the link between war time exposure to Agent Orange and prostate cancer had a low likelihood of detecting a significant correlation with prostate cancer due to the relatively young age of the Vietnam veteran population. This population is now reaching an age in which prostate cancer is more likely, adding potential new information to our understanding of any relationship between Agent Orange exposure and prostate cancer incidence. While the association is unclear at the current time, the next 10 to 15 years will, in all likelihood, clarify the risk of prostate cancer in Agent Orange-exposed individuals. Until that time, diligent prostate cancer screening in patients with a history of Agent Orange exposure is reasonable.

Agent Orange and Prostate Cancer: Fact or Fiction? (Last modified July 2008)

Is the PSA test still being used as benchmark in clinical trials,I hear you ask?

Lets have a quick look and see what we can find:

Cancer vaccines (March 2009)

Planning for the clinical development of GVX 3322 has continued and discussions with leading clinical oncologists are defining the key parameters for a prostate cancer trial. It is evident that the design of this trial will depend critically on the data from the current trial and, in particular, on the PSA-response rate that is observed. The Company is in discussions with the University of Southampton and Cancer Research Technology to obtain these data.
MMG-Development update

Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a
Phase 2 Picoplatin Trial in Patients with Prostate Cancer (February 2009)

The encouraging PSA response rates, time to PSA progression and radiologic responses rates, combined with the promising safety results observed to date, support further development of picoplatin in combination with docetaxel and prednisone in advanced prostate cancer patients
Phase 2 Picoplatin Trial in Patients with Prostate Cancer

PSA Response Signatures - A Powerful New Prognostic Indicator After Radiation For Prostate Cancer?(January 2009)

We are also interested in the potential prognostic value of PRS typing during neo-adjuvant androgen deprivation. We will learn more about this issue from the successor trial to 96.01, known as RADAR . It includes six months neo-adjuvant leuprolide plus radiation in the control arm of this trial.
PSA Response Signatures

That was just after a quick Googleeee :-)

I don't remember seeing this before,a very interesting read even if two years old.The chart-What to do with an abnormal PSA test is also of interest.

What to Do with an Abnormal PSA Test

World's Longest Prostate Cancer Cure Rates Published at Clinical Oncology Meeting
PRWeb

March 06, 2009

Prostate Cancer Cure Rates are very important to most patients. 'Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease treated with brachytherapy and supplemental conformal radiation' reports an astonishing 16-year Prostate Cancer Cure Rate, was presented by radiation oncologist and principal investigator Michael J. Dattoli, MD.

The study on Prostate Cancer Cure Rates consists of a group of 321 patients treated by Dr. Dattoli between 1992 and 1997, each of whom was diagnosed with prostate cancer categorized as at either intermediate-risk or high-risk of extra-capsular extension.' 157 patients were categorized as intermediate-risk; 164 were high-risk. The stratification conforms to the National Comprehensive Cancer Network (http://www.nccn.org) guidelines and is of importance because it defines whether the cancer cells are at risk of having spread beyond the prostate gland, making 'cure' by traditional surgical approaches virtually impossible.

http://www.topix.net/content/prweb/2009/03/worlds-longest-prostate-cancer-cure-rates-published-at-clinical-oncology-meeting

World-Renowned Prostate Surgeon David B. Samadi, M.D. Clarifies Prostate Screening and Treatment Options for Primary Care Physicians in Geriatrics Medical Journal

March 5 2009

Prostate Cancer Screening Options

The current methods for diagnosing prostate cancer involve using serum prostate-specific antigen (PSA) and digital rectal examination (DRE) tests. Although these methods have saved countless lives through early diagnosis since their adoption in the late 1980s, the interpretation of PSA results remains a challenge due to the natural fluctuations of PSA levels even in healthy men. In the article, Dr. Samadi predicts, "It now appears likely that PSA velocity (calculated over the course of at least 18 months) is more predictive of prostate cancer than the absolute PSA value."

http://www.marketwire.com/press-release/RoboticoncologyCom-957805.html

Prostate Cancer: The New Landscape - Abstract

Friday, 06 March 2009

This review highlights current features of the changing landscape of the US population with newly diagnosed prostate cancer and discusses new treatment options utilizing noninvasive or minimally invasive management.

Recent evidence of significant changes in the current prostate cancer landscape is based on clinical data and pathological specimens after radical prostatectomy that suggest a further increase of the low-risk patient population that may require reconsideration of treatment options. For a select cohort of patients with low-risk features, based on the D'Amico definition, active surveillance or focal ablative therapy may be a rational alternative to surgical prostatectomy or whole-gland radiation therapy that still dominate as the main treatment approaches for localized prostate cancer.

As the prostate-specific antigen era continues to mature, we continue to witness stage migration. A growing segment of the localized prostate cancer patient population has very low-volume, low-grade disease. Although active surveillance may be an appropriate approach for a selected group of patients, the progression requiring whole-gland therapy remains a challenge. Organ-sparing focal therapy might ideally fill the gap between a surveillance strategy and whole-gland treatment providing a reasonable balance between cancer control and quality of life.

Written by:
Moul JW, Mouraviev V, Sun L, Schroeck FR, Polascik TJ.

http://www.urotoday.com/61/browse_categories/prostate_cancer/prostate_cancer_the_new_landscape__abstract.html

Are prostate cancer screening trials a giant waste of time and money?

Posted on March 4, 2009 by E. Michael D. ("Mike") Scott

"It is tempting to wonder whether we have over-emphasized the idea that the value of screening is directly correlated with risk for mortality. That may well be the case when the risk of early death is the actual priority. However, when the real risk to most patients may be their quality of life over time, maybe screening is every bit as justified, but on quite different grounds."

http://prostatecancerinfolink.net/2009/03/04/are-prostate-cancer-screening-trials-a-giant-waste-of-time-and-money/